CHR. OLESEN SYNTHESIS A/S: Financial statements 2012
CVR: 33964870
Source: annual report 2012, Danish Business Authority
17/10/2011 – 30/09/2012
CHR. OLESEN SYNTHESIS A/S (CVR 33964870) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -934,374 and a net result of DKK -1,636,018. Equity in the 2012 report amounted to DKK -1,164,955.
- Gross Profit
- DKK -934,374
- Profit/Loss
- DKK -1,636,018
- Equity
- DKK -1,164,955
- Total Assets
- DKK 2,070,083
Official annual report
Keep an eye on CHR. OLESEN SYNTHESIS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 1, 2012, Terje Aarbogh has joined the board of directors of CHR. OLESEN SYNTHESIS A/S.
As of May 1, 2012, Allan Ardensø has left the board of directors of CHR. OLESEN SYNTHESIS A/S.
As of January 1, 2012, Terje Aarbogh is registered as director of CHR. OLESEN SYNTHESIS A/S.
As of January 1, 2012, Svend Aage Johansen has stepped down as director of CHR. OLESEN SYNTHESIS A/S.
About CHR. OLESEN SYNTHESIS A/S
CHR. OLESEN SYNTHESIS A/S is a Danish company of the type Aktieselskab based in Hvidovre, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Thomas Michael Moestrup. The board consists of Jean-Francois Hilaire (chair), Joseph Nivaro and Thomas Michael Moestrup. The company is owned by Samfara/Bering Bidco Limited. The company has 97 employees (2026). In 2025, the company reported a gross profit of EUR 6,958,825 and a net result of EUR -2,299,046 compared with EUR 7,391,800 the year before. Equity in the 2025 report amounted to EUR -9,489,900.
